Breast cancer is not one disease, and eliminating the disparities in outcomes requires improved understanding of biology and implementation of systemwide clinical innovation to deliver high-quality care to all women, one woman at a time. Representing 14.0% of all new cancer diagnoses, an estimated 232 670 new cases of breast cancer will occur in 2014, and an estimated 40 000 women will die of the disease.1,2 Despite significant gains in the treatment of the disease, leading to an overall reduction in breast cancer mortality, black women continue to die disproportionately from aggressive forms of breast cancer. There has been no fundamental shift in the approach to treatment for early-stage breast cancer based on biology.
Daly B, Olopade OI. Race, Ethnicity, and the Diagnosis of Breast Cancer. JAMA. 2015;313(2):141–142. doi:10.1001/jama.2014.17323
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: